Mayr, Lisa
Mager, Leah
Gabler-Pamer, Lisa
Kirchhofer, Dominik
Freund, Julia
Schwark, Kallen
Lau, Benison
Machreich, Sarah
Senfter, Daniel
Neumüller, Mia
Lang, Alexandra
Madlener, Sibylle
Laemmerer, Anna
Bruckner, Katharina
Jaunecker, Carola N.
Robl, Bernhard
Walter, Romina
Schueler, Julia
Peyrl, Andreas
Azizi, Amedeo A.
Dorfer, Christian
Roessler, Karl
Spiegl-Kreinecker, Sabine
Haberler, Christine
Federico, Aniello
Gopisetty, Apurva
Schleiermacher, Gudrun
Pfister, Stefan M.
Geoerger, Birgit
Chesler, Louis
Vassal, Gilles
Kool, Marcel
Müllauer, Leonhard
Koschmann, Carl
Berger, Walter
Gojo, Johannes
Lötsch, Daniela
Funding for this research was provided by:
Medical-Scientific Fund of the Mayor of the federal capital Vienna (19086)
Medical-Scientific Fund of the Mayor of the federal capital Vienna (21165)
Physician Researcher Pathway Scholarship of the Medical University of Vienna
National Institutes of Health Grant (R01-NS119231)
DOD Grant (CA201129P1)
“Forschungsgesellschaft für Cerebrale Tumore”
Austrian Science Fund - FWF (T 906-B28)
Initiative Krebsforschung-Grant
Article History
Received: 28 January 2026
Accepted: 29 April 2026
First Online: 16 May 2026
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Medical University of Vienna (Date 30.05.2023/No 1244/2016). GZ 2024 − 0.901.338 of the Medical University of Vienna and Austrian Ministry for Science and Technology (subcutaneous mouse model), G23/036 of the Regierungspräsidium Freiburg im Breisgau (orthotopic mouse model).Informed consent was obtained from all individual participants or the parents included in the study.
: Consent for publication was obtained from all individual participants or the parents included in the study.
: J.G. is consultant, advisory board participant and received honoraria for Novartis, Roche, Rhythm Pharmaceuticals, and Ipsen (not relevant to this study).